Scribble in hematopoietic stem cell activity
造血干细胞活性的涂鸦
基本信息
- 批准号:9934991
- 负责人:
- 金额:$ 3.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AssesBlood CellsBone MarrowCell CycleCell Cycle InhibitionCell Cycle ProgressionCell Differentiation processCell PolarityCell ProliferationCell physiologyCellsChronic DiseaseComplexConfocal MicroscopyCuesCytoplasmDataDevelopmentDiseaseEuchromatinExhibitsFailureFlow CytometryGeneticGenetic DiseasesGenetic TranscriptionGoalsHematological DiseaseHematologyHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsImageIndividualInterferon Type IInterferonsInterventionLabelLarvaLeucine-Rich RepeatMalignant NeoplasmsMeasuresMediatingMesenchymal Stem CellsMolecularMolecular TargetMusNuclearNuclear TranslocationOrgan SizePathway interactionsPharmacologyPhosphorylationPhosphotransferasesPopulationProteinsRegulationResearch PersonnelResistanceResponse ElementsReverse Transcriptase Polymerase Chain ReactionRoleSTAT1 geneSTAT2 geneSignal PathwaySignal TransductionStem cell transplantStem cellsStressStructureTestingTherapeuticTranslatingTransplantationVirus DiseasesWorkcancer geneticscell behaviorcell typechemotherapycytokinecytopeniaexhaustionhematopoietic stem cell fatehematopoietic stem cell quiescencehematopoietic stem cell self-renewalimprovedin vivoinsightleukemiamembermutantnovelpolarized cellprogenitorprogramspublic health relevancereconstitutionresponseself-renewaltranscriptome
项目摘要
DESCRIPTION (provided by applicant): The potential of hematopoietic stem cells (HSC) to reconstitute the hematopoietic system has allowed for the development of transplantation approaches to treat cancer and hematologic diseases. Cell cycle status of HSC defines their ability to engraft in conditioned recipients and has been hypothesized as a mechanism for chemotherapy-resistant HSC-derived leukemias. HSC are highly quiescent cells with the ability to rapidly enter the cell cycle and differentiate through changes in their polarity and disposition
of intracellular molecular fate determinants in response to microenvironment (ME) cues. In bone marrow (BM) hematopoiesis, interferons type I (IFN-I), a ME cytokine produced in response to viral infection, have been shown to be a crucial positive regulator to induce proliferation of otherwise quiescent hematopoietic stem cells (qHSC). Our preliminary data indicate that Scribble deficient HSC are insensitive to IFN-I and retain cellular quiescence in vivo. Our preliminary data also show that the Hippo effector Yap1, which also regulates stem cell proliferation in response to ME signals, is polarized and co-localizes in the cytoplasm with Scribble in wild type HSC. Deficiency of Scribble in HSC results in Yap1 translocation to nuclear euchromatin suggesting a novel Scribble-mediated mechanism used to protect qHSC from potential damage associated with cellular activation. Our data suggests that Scribble distinctly regulates HSC cell cycle progression in a context-dependent manner. We believe that ME IFN-I induced HSC proliferative signaling program depends on Scribble and that Scribble deficiency abrogates HSC polarization leading to reduced quiescence and subsequent HSC exhaustion through activation of downstream Hippo effectors. To gain insight into these ME dependent signaling pathways that control HSC activity, we plan to analyze both IFN-I response signaling pathways and Hippo signaling in Scribble proficient and deficient HSC. We will utilize flow cytometry and confocal microscopy to define a role for Scribble in mediating such signals. Functionally, we will test the reconstitution abilities of wild type and Scribble structure-functio mutants in Scribble deficient HSC through serial transplantations. Dissecting the microenvironment dependent Scribble-mediated molecular mechanisms that govern HSC quiescence will help refine the significance and therapeutic potential of naturally occurring IFN molecules and identify novel targets for intervention in HSC disease.
描述(由申请人提供):造血干细胞(HSC)重建造血系统的潜力已允许开发治疗癌症和血液疾病的移植方法,HSC的细胞周期状态决定了它们移植到条件接受者体内的能力。已被重新视为化疗耐药性 HSC 衍生性白血病的一种机制 HSC 是高度静止的细胞,能够快速进入细胞周期并通过其变化进行分化。极性和倾向
细胞内分子命运决定因素对微环境 (ME) 信号的反应在骨髓 (BM) 造血过程中,I 型干扰素 (IFN-I) 是一种 ME 响应病毒感染而产生的细胞因子,已被证明是至关重要的正调节因子。我们的初步数据表明,Scribble 缺陷型 HSC 对 IFN-I 不敏感,并且在体内保持细胞静止状态。 Hippo 效应子 Yap1 也响应 ME 信号调节干细胞增殖,在野生型 HSC 中与 Scribble 共定位于细胞质中,HSC 中 Scribble 的缺陷导致 Yap1 易位至核常染色质,这表明存在一种新的 Scribble 介导的现象。我们的数据表明,Scribble 以上下文依赖性方式明显调节 HSC 细胞周期进程。 IFN-I 诱导的 HSC 增殖信号传导程序依赖于 Scribble,而 Scribble 缺陷会消除 HSC 极化,从而通过下游 Hippo 效应器的激活减少静止和随后的 HSC 耗竭。为了深入了解这些控制 HSC 活性的 ME 依赖性信号传导途径,我们计划分析 Scribble 熟练和缺陷的 HSC 中的 IFN-I 反应信号通路和 Hippo 信号传导 我们将利用流式细胞术和共聚焦显微镜来定义 Scribble 在介导此类作用中的作用。在功能上,我们将通过连续移植测试 Scribble 缺陷型 HSC 中野生型和 Scribble 结构功能突变体的重建能力,剖析控制 HSC 静止的微环境依赖的 Scribble 介导的分子机制将有助于完善自然的意义和治疗潜力。 IFN 分子并确定干预 HSC 疾病的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Jordan Althoff其他文献
Mark Jordan Althoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Jordan Althoff', 18)}}的其他基金
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
了解 MCL1 在 Ven/Aza 耐药 AML 中的独特依赖性
- 批准号:
10671482 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
了解 MCL1 在 Ven/Aza 耐药 AML 中的独特依赖性
- 批准号:
10535785 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
相似国自然基金
免疫相关性全血细胞减少症患者骨髓造血细胞膜靶抗原TRAPPC4的研究
- 批准号:81770118
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
补肾生血药调控JAK2-STATs通路纠正造血细胞增殖-凋亡失衡改善化疗后骨髓抑制的机制研究
- 批准号:81774176
- 批准年份:2017
- 资助金额:53.0 万元
- 项目类别:面上项目
骨髓造血细胞抑制间质干细胞向脂肪细胞分化的实验研究
- 批准号:81270568
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
源于阿胶的新型骨髓造血细胞增殖肽的作用机理研究
- 批准号:30973974
- 批准年份:2009
- 资助金额:33.0 万元
- 项目类别:面上项目
骨髓库姆试验(+)血细胞减少症自身抗体靶抗原初步研究
- 批准号:30971285
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Autophagy Engagement and Hematopoietic Stem Cell Maintenance During Aging
衰老过程中的自噬参与和造血干细胞维持
- 批准号:
9910584 - 财政年份:2020
- 资助金额:
$ 3.75万 - 项目类别:
Regulation of oxidative stress and vascular remodeling by EBP50
EBP50 对氧化应激和血管重塑的调节
- 批准号:
9920603 - 财政年份:2017
- 资助金额:
$ 3.75万 - 项目类别:
Targeting mononuclear phagocytes development in alcohol induced liver damage: pathological and immunological pathways
酒精性肝损伤中单核吞噬细胞的发育:病理学和免疫学途径
- 批准号:
9766987 - 财政年份:2017
- 资助金额:
$ 3.75万 - 项目类别:
Targeting mononuclear phagocytes development in alcohol induced liver damage: pathological and immunological pathways
酒精性肝损伤中单核吞噬细胞的发育:病理学和免疫学途径
- 批准号:
9445736 - 财政年份:2017
- 资助金额:
$ 3.75万 - 项目类别:
Regulation of oxidative stress and vascular remodeling by EBP50
EBP50 对氧化应激和血管重塑的调节
- 批准号:
9284602 - 财政年份:2017
- 资助金额:
$ 3.75万 - 项目类别: